180 related articles for article (PubMed ID: 22706787)
21. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
MacLaren R; Bond CA
Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
[TBL] [Abstract][Full Text] [Related]
22. Guidelines on the provision of facilities for the care of adult patients with haematological malignancies (including leukaemia and lymphoma and severe bone marrow failure). British Committee for Standards in Haematology Clinical Haematology Task Force.
Clin Lab Haematol; 1995 Mar; 17(1):3-10. PubMed ID: 7621625
[TBL] [Abstract][Full Text] [Related]
23. Pharmaceutical care in community pharmacies: practice and research in Peru.
Alvarez-Risco A; van Mil JW
Ann Pharmacother; 2007 Dec; 41(12):2032-7. PubMed ID: 17940126
[TBL] [Abstract][Full Text] [Related]
24. Increasing pharmacy productivity by expanding the role of pharmacy technicians.
Kalman MK; Witkowski DE; Ogawa GS
Am J Hosp Pharm; 1992 Jan; 49(1):84-9. PubMed ID: 1570872
[TBL] [Abstract][Full Text] [Related]
25. Impact of clinical pharmacists in outpatient oncology practices: A review.
Gatwood J; Gatwood K; Gabre E; Alexander M
Am J Health Syst Pharm; 2017 Oct; 74(19):1549-1557. PubMed ID: 28947527
[TBL] [Abstract][Full Text] [Related]
26. Pharmaceutical care in chronic kidney disease: experience at Grenoble University Hospital from 2006 to 2010.
Belaiche S; Romanet T; Bell R; Calop J; Allenet B; Zaoui P
J Nephrol; 2012; 25(4):558-65. PubMed ID: 22101677
[TBL] [Abstract][Full Text] [Related]
27. Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit.
Han JM; Ah YM; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Int J Clin Pharm; 2016 Oct; 38(5):1124-32. PubMed ID: 27365091
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting.
Shah S; Dowell J; Greene S
Ann Pharmacother; 2006 Sep; 40(9):1527-33. PubMed ID: 16882869
[TBL] [Abstract][Full Text] [Related]
29. The pharmacist as a trauma team member.
Brent RJ; Poltorak I
Hosp Pharm; 1987 Feb; 22(2):152-5. PubMed ID: 10280298
[TBL] [Abstract][Full Text] [Related]
30. Time and cost requirements for decentralized pharmacist activities.
Iglar AM; Osland CS; Ploetz PA; Thielke TS
Am J Hosp Pharm; 1990 Mar; 47(3):572-8. PubMed ID: 2316541
[TBL] [Abstract][Full Text] [Related]
31. Pharmacist's role in home i.v. therapy.
McAllister JC
Am J Hosp Pharm; 1989 Jul; 46(7 Pt 2):S10-4. PubMed ID: 2505613
[TBL] [Abstract][Full Text] [Related]
32. The emerging role of psychiatric pharmacists.
Cohen LJ
Am J Manag Care; 1999 Jul; 5(10 Suppl):S621-9; quiz S630-3. PubMed ID: 10539497
[TBL] [Abstract][Full Text] [Related]
33. Taking the lead: community pharmacists' perception of their role potential within the primary care team.
Dobson RT; Taylor JG; Henry CJ; Lachaine J; Zello GA; Keegan DL; Forbes DA
Res Social Adm Pharm; 2009 Dec; 5(4):327-36. PubMed ID: 19962676
[TBL] [Abstract][Full Text] [Related]
34. 1992 National Clinical Pharmacy Services Study.
Bond CA; Raehl CL; Pitterle ME
Pharmacotherapy; 1994; 14(3):282-304. PubMed ID: 7937270
[TBL] [Abstract][Full Text] [Related]
35. Collaboration: what can health-care organizations learn about pharmacist retention from Magnet status hospitals?
Brahm N; Kelly-Rehm M; Farmer KC
Res Social Adm Pharm; 2009 Dec; 5(4):382-9. PubMed ID: 19962681
[No Abstract] [Full Text] [Related]
36. Documentation of chemotherapy infusion preparation costs in academic- and community-based oncology practices.
Brixner DI; Oderda GM; Nickman NA; Beveridge R; Jorgenson JA
J Natl Compr Canc Netw; 2006 Mar; 4(3):197-208. PubMed ID: 16507268
[TBL] [Abstract][Full Text] [Related]
37. The activity of palliative care team pharmacists in designated cancer hospitals: a nationwide survey in Japan.
Ise Y; Morita T; Katayama S; Kizawa Y
J Pain Symptom Manage; 2014 Mar; 47(3):588-93. PubMed ID: 24018207
[TBL] [Abstract][Full Text] [Related]
38. Pharmacist roles in the management of patients with type 2 diabetes.
Sisson E; Kuhn C
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S41-5. PubMed ID: 19801364
[TBL] [Abstract][Full Text] [Related]
39. If there are expert systems and dose checks, why do we still need the clinical pharmacist?
Wong WM; Ignoffo RF
Pharm Pract Manag Q; 1996 Apr; 16(1):50-8. PubMed ID: 10157740
[TBL] [Abstract][Full Text] [Related]
40. [Importance of Pharmaceutical Training and Clinical Research at Medical Facilities].
Myotoku M
Yakugaku Zasshi; 2017; 137(1):13-16. PubMed ID: 28049889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
